Please login to the form below

Not currently logged in
Email:
Password:

Horizon Discovery appoints Eric Rhodes as chief technical officer

Former Sangamo Biosciences VP of business development to join personalised medicine specialists

Eric Rhodes - Horizon, chief technology officerEric Rhodes has been appointed chief technical officer at UK-based Horizon Discovery.

Rhodes joins the personalised medicine specialists from his role as business development director at life science and technology company Sigma-Aldrich Corp.

In his new position, Rhodes will use his experience of gene-targeting therapeutics to advise R&D and marketing for Horizon's rAAV-mediated genome editing technology, this enables genes in a human cell-line to be altered quickly and reliably, according to the company.

Prior to his position as Sigma-Aldrich, Rhodes was VP of business development at Sangamo Biosciences, a clinical stage biopharmaceutical company that focuses on DNA research, from 1998 until 2008.

In both roles he was responsible for the commercialisation of gene-editing technology, during which time he made licensing deals with more than 24 biotech and pharma companies.

Dr Darrin Disley, CEO of Horizon, said: “Eric has a proven track record of delivery in the biotech industry, backed by a broad knowledge of the gene-editing field, and so brings added perspective to our technology, IP and commercial strategies.

“I'm delighted to welcome him to Horizon, and look forward to seeing him make an impact within an innovative, dynamic and entrepreneurial environment.”

27th January 2012

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Graphite

Graphite is a digital agency which partners with globally respected pharma and healthcare organisations to create powerful digital experiences. We...

Latest intelligence

Webinar:
Securing a future for telehealth with immersive market research insights...
Accelerating patient recruitment in clinical trials with the Clinical Enrolment Managers (CEMs)
How Innovative Trials' global Clinical Enrolment Managers (CEMs) give clinical trial sites the local touch...
Six ways to improve diversity in clinical trials
Diversity is becoming increasingly important as a focus of clinical trials. This whitepaper gives six approaches that could be implemented to help make diversity a bigger focus on your clinical...